CD140a, Human (Olaratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-CD140a, Human (Olaratumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD140a, Human (Olaratumab biosimilar) |
| Clone | Olaratumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | IF, IP, Neut, FuncS, ELISA, FCM |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human CD140a Recombinant Antibody (Olaratumab). Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses"). |
| Immunogen | n/a |
| Other Names | Anti-CD140a Recombinant Antibody, Research Grade Olaratumab, Anti-Human CD140a Recombinant Antibody(Olaratumab), 3G3, IMC-3G3, LY3012207, Antibody Drug Analogues, Monoclonal Antibody, YR1233, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1024603-93-7 |
| Catalog # | YR1233 |
| Price | please inquire |
| Order / More Info | CD140a, Human (Olaratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies